
Meta Seizes Its Moment to Spend Aggressively in the AI Race
About this episode
Watch Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney and Norah Mulinda
-Kurt Wagner, Bloomberg Tech Reporter, discusses Meta earnings. Meta Platforms Inc. is increasing spending next year, with executives saying now is the time to seize on investment opportunities in artificial intelligence.
-Damian Garde, Bloomberg News Health Reporter, discusses how a trial of Eli Lilly & Co.'s diabetes drug Mounjaro fell short of expectations that it would do a better job of preventing heart attacks and strokes than its older medicine Trulicity.
-Kunjan Sobhani, Bloomberg Intelligence Senior Semiconductor Analyst, recaps Qualcomm earnings. Shares of Qualcomm Inc., the biggest maker of chips that run smartphones, fell after the company reported lackluster growth in that market, fueling concerns that tariffs will take a toll on the industry.
-Geetha Ranganathan, Bloomberg Intelligence Analyst on US Media, discusses Comcast earnings. Comcast Corp. lost 226,000 domestic broadband subscribers in the quarter ended June 30, but this was better than analysts' forecasts for losses of 257,000.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Bloomberg Intelligence publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Bloomberg Intelligence

GE to Buy Consolidated Precision Products for $11.75 Billion
Bloomberg Intelligence

Introducing: Bloomberg Money
Bloomberg Intelligence

Bloomberg Money: Premium Travel, Fast Fashion, Luxury at the US Open & The Cost...
Bloomberg Intelligence

Anthropic Finalizing $15 Billion Pre-IPO Credit Facility
Bloomberg Intelligence